Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Baricitinib for Oral Lichen Planus
NCT06158113Phase 2Completed
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Mar 2024
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
A Phase 2 trial of baricitinib in oral lichen planus (OLP), sponsored by University of North Carolina at Chapel Hill. Started Mar 2024; status: completed.
02
Drugs
baricitinib
03
Conditions
oral lichen planus (OLP)
Beyond the preview
Go deeper on NCT06158113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06158113.